88852-12-4 Limaprost CAS NO.88852-12-4
- FOB Price: USD: 500.00-500.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,
- Available Specifications:
A(10-15)Kilogram
- Product Details
Keywords
- 88852-12-4 Limaprost
- 88852-12-4 Limaprost
- 88852-12-4 Limaprost
Quick Details
- ProName: 88852-12-4 Limaprost
- CasNo: 88852-12-4
- Appearance: Powder
- Application: Organic Chemicals
- DeliveryTime: according to client's demand quantity
- PackAge: as requested
- Port: SHANGHAI
- ProductionCapacity: 100 Metric Ton/Day
- Purity: 99%
- Storage: room temperature
- Transportation: by sea
- LimitNum: 1 Kilogram
- Heavy metal: 10ppm
- Grade: Industrial Grade,Pharma Grade
- Transportation: LCL
Superiority
Product Name: Limaprost
Synonyms: 17S,20-Dimethyl-trans-D2-PGE1 compd. with a-cyclodextrin;2,4,7,9,12,14,17,19,22,24,27,29-Dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane, a-cyclodextrin deriv.;2-Heptenoic acid, 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methyl-1-nonenyl]-5-oxocyclopentyl]-, (2E)-, compd. with a-cyclodextrin (9CI);a-Cyclodextrin, compd. with (2E)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methyl-1-nonenyl]-5-oxocyclopentyl]-2-heptenoic acid (9CI);a-Cyclodextrin, compd. with (2E,11a,13E,15S,17S)-11,15-dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic acid;Limaprost a-cyclodextrin clathrate;limaprost alfadex;OP 1206-a-cyclodextrin
CAS: 88852-12-4
MF: C36H60O30.C22H36O5
MW: 1353.36
EINECS:
Product Categories:
Mol File: 88852-12-4.mol
Limaprost Usage And Synthesis
Description Limaprost is an orally-active antithrombotic and vasodilator structurally related to alprostadil. Oral administration of limaprost causes a dose-dependent inhibition of platelet aggregation, an increase in platelet CAMP and a mild suppression of platelet adhesiveness. In patients with pulmonary emphysema, tuberculosis, and chronic lung disease, treatment with limaprost reportedly produces significant cardiac improvements.
Details
Product Name: Limaprost
Synonyms: 17S,20-Dimethyl-trans-D2-PGE1 compd. with a-cyclodextrin;2,4,7,9,12,14,17,19,22,24,27,29-Dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane, a-cyclodextrin deriv.;2-Heptenoic acid, 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methyl-1-nonenyl]-5-oxocyclopentyl]-, (2E)-, compd. with a-cyclodextrin (9CI);a-Cyclodextrin, compd. with (2E)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methyl-1-nonenyl]-5-oxocyclopentyl]-2-heptenoic acid (9CI);a-Cyclodextrin, compd. with (2E,11a,13E,15S,17S)-11,15-dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic acid;Limaprost a-cyclodextrin clathrate;limaprost alfadex;OP 1206-a-cyclodextrin
CAS: 88852-12-4
MF: C36H60O30.C22H36O5
MW: 1353.36
EINECS:
Product Categories:
Mol File: 88852-12-4.mol
Limaprost Usage And Synthesis
Description Limaprost is an orally-active antithrombotic and vasodilator structurally related to alprostadil. Oral administration of limaprost causes a dose-dependent inhibition of platelet aggregation, an increase in platelet CAMP and a mild suppression of platelet adhesiveness. In patients with pulmonary emphysema, tuberculosis, and chronic lung disease, treatment with limaprost reportedly produces significant cardiac improvements.